ONTXW - (Onconova Therapeutics Inc.)

ONTXWのニュース

   Onconova Therapeutics Highlights Corporate Progress and Reports Second Quarter 2020 Financial Results  2020/08/12 20:05:00 GlobeNewswire
INSPIRE Phase 3 trial survival events reachedTopline data anticipated Q3-2020 Conference call and webcast scheduled today, August 12, at 4:30 p.m. ET …
   Onconova Therapeutics to Provide Corporate Update and Second Quarter 2020 Earnings on August 12, 2020  2020/08/07 12:00:00 GlobeNewswire
Company to host conference call and webcast at 4:30 p.m. Eastern Time on Wednesday, August 12
   Onconova Therapeutics Announces that the Required Number of Survival Events Has Been Reached for the Pivotal Phase 3 INSPIRE Trial Data Analysis  2020/07/29 17:30:00 GlobeNewswire
Topline INSPIRE Results are Expected by the End of the Third Quarter of 2020
   Onconova files for NIH funding for studies of rigosertib in COVID-19 (NASDAQ:ONTX)  2020/07/27 12:25:37 Seeking Alpha
Onconova Therapeutics (NASDAQ:ONTX) has submitted an application to the National Institute of Allergy and Infectious Disease (NIAID) aimed at obtaining fun
   Onconova Therapeutics Submits Application for Rigosertib to Participate in Federally Funded Human Studies in COVID-19 Disease  2020/07/27 12:00:00 Yahoo Finance
Preclinical experiments with rigosertib in cellular models demonstrate marked inhibition of SARS-CoV-2 replicationNEWTOWN, Pa., July 27, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products
   Onconova Therapeutics Highlights Corporate Progress and Reports Second Quarter 2020 Financial Results  2020/08/12 20:05:00 GlobeNewswire
INSPIRE Phase 3 trial survival events reachedTopline data anticipated Q3-2020 Conference call and webcast scheduled today, August 12, at 4:30 p.m. ET …
   Onconova Therapeutics to Provide Corporate Update and Second Quarter 2020 Earnings on August 12, 2020  2020/08/07 12:00:00 GlobeNewswire
Company to host conference call and webcast at 4:30 p.m. Eastern Time on Wednesday, August 12
   Onconova Therapeutics Announces that the Required Number of Survival Events Has Been Reached for the Pivotal Phase 3 INSPIRE Trial Data Analysis  2020/07/29 17:30:00 GlobeNewswire
Topline INSPIRE Results are Expected by the End of the Third Quarter of 2020
   Onconova files for NIH funding for studies of rigosertib in COVID-19 (NASDAQ:ONTX)  2020/07/27 12:25:37 Seeking Alpha
Onconova Therapeutics (NASDAQ:ONTX) has submitted an application to the National Institute of Allergy and Infectious Disease (NIAID) aimed at obtaining fun
   Onconova Therapeutics Submits Application for Rigosertib to Participate in Federally Funded Human Studies in COVID-19 Disease  2020/07/27 12:00:00 Yahoo Finance
Preclinical experiments with rigosertib in cellular models demonstrate marked inhibition of SARS-CoV-2 replicationNEWTOWN, Pa., July 27, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products
   Onconova Therapeutics Highlights Corporate Progress and Reports Second Quarter 2020 Financial Results  2020/08/12 20:05:00 GlobeNewswire
INSPIRE Phase 3 trial survival events reachedTopline data anticipated Q3-2020 Conference call and webcast scheduled today, August 12, at 4:30 p.m. ET …
   Onconova Therapeutics to Provide Corporate Update and Second Quarter 2020 Earnings on August 12, 2020  2020/08/07 12:00:00 GlobeNewswire
Company to host conference call and webcast at 4:30 p.m. Eastern Time on Wednesday, August 12
   Onconova Therapeutics Announces that the Required Number of Survival Events Has Been Reached for the Pivotal Phase 3 INSPIRE Trial Data Analysis  2020/07/29 17:30:00 GlobeNewswire
Topline INSPIRE Results are Expected by the End of the Third Quarter of 2020
   Onconova files for NIH funding for studies of rigosertib in COVID-19 (NASDAQ:ONTX)  2020/07/27 12:25:37 Seeking Alpha
Onconova Therapeutics (NASDAQ:ONTX) has submitted an application to the National Institute of Allergy and Infectious Disease (NIAID) aimed at obtaining fun
   Onconova Therapeutics Submits Application for Rigosertib to Participate in Federally Funded Human Studies in COVID-19 Disease  2020/07/27 12:00:00 Yahoo Finance
Preclinical experiments with rigosertib in cellular models demonstrate marked inhibition of SARS-CoV-2 replicationNEWTOWN, Pa., July 27, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products

calendar